Drug Trial News

RSS

Twin study on the increased cardiometabolic risk in obesity

A unique monozygotic twin study by researchers from the Finnish Twin Cohort, Helsinki University Central Hospital, and VTT Technical Research Centre of Finland found that obesity, already in its early stages and independent of genetic influences, is associated with deleterious alterations in the lipid metabolism known to facilitate atherogenesis, inflammation and insulin resistance.

15 Feb 2007

Marijuana gives relief from chronic pain for AIDS sufferers

Researchers have found that people suffering from chronic foot pain as a result of the AIDS virus gained relief from smoking marijuana.

14 Feb 2007

New oral blood thinner

A new oral blood thinner is being compared to an old standby to see if it works as well and is easier to manage long term, researchers say.

13 Feb 2007

Nagging spouse? nonconscious relationship reactance

New research findings now appearing online in the Journal of Experimental Social Psychology began with a professor's desire to understand why her husband often seemed to ignore her requests for help around the house.

13 Feb 2007

Benefits of two cochlear implants in deaf children

Nature has outfitted us with a pair of ears for good reason: having two ears enhances hearing. University of Wisconsin-Madison scientists are now examining whether this is also true for the growing numbers of deaf children who've received not one, but two, cochlear implants to help them hear

13 Feb 2007

Researchers discover why antipsychotic drugs cause weight gain

Researchers at Johns Hopkins University in Baltimore have discovered why some drugs used to treat mental illnesses such as schizophrenia, cause patients to gain a lot of weight.

13 Feb 2007

Switching treatment to exemestane after 2-3 years on tamoxifen, improves survival

The Intergroup Exemestane Study (IES), an extensive, international study, tested the superiority of switching to exemestane (an aromatase inhibitor) from tamoxifen in patients with early breast cancer.

13 Feb 2007

Variation in gene caspase-8 may help protect against breast cancer

A large-scale analysis of data on breast cancer risk has concluded that a common variation in the gene caspase-8 (CASP8) is associated with a somewhat lower risk of the disease. Variants are small changes that occur in a gene sequence.

13 Feb 2007

Some doctors do not tell patients about treatments they oppose

Some physicians do not tell patients about treatments -- such as contraception, abortion or sedation for dying patients -- that they are morally opposed to, according to a study published in the Feb. 8 edition of the New England Journal of Medicine, the Washington Post reports.

13 Feb 2007

Indicators for risk of heart disease are higher in passive smokers

Exposure to second-hand smoke at work, home or elsewhere results in a disproportionate rise in markers that increase the risk of cardiovascular disease, University of Nottingham researchers have found.

12 Feb 2007

Nanoparticle boost for antitumor vaccines

Researchers have known for some time that certain sequences of synthetic DNA induce potent immune responses when injected into animals and humans.

12 Feb 2007

Cancer breakthrough - first treatment to directly target tumor supply

For the first time, physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City have demonstrated in patients the ability of an antibody to directly target the blood supply of a wide variety of tumors, leaving healthy tissues unharmed.

12 Feb 2007

Expanded endonasal approach surgery removes tumors once deemed to be inoperable

A first-of-its-kind study published in the February issue of the Journal of Neurosurgery: Pediatrics suggests endoscopic brain surgery, pioneered by surgeons at the University of Pittsburgh Medical Center, has the potential to be safer and often more effective than conventional surgery in children with life-threatening conditions.

12 Feb 2007

Combination drug treatment helps beat mesothelioma

People with mesothelioma - a form of cancer associated with asbestos exposure - have a higher survival rate when treated with a combination of two cancer drugs, a large multicenter study finds.

12 Feb 2007

Mood changes in response to psychosocial stress in healthy young women: effects of pretreatment with Cortisol

German researchers have found additional evidence that the stress hormone cortisol can have positive effects in certain situations.

12 Feb 2007

Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma

For breast cancer patients taking tamoxifen, switching to an aromatase inhibitor within three years significantly improves survival rates, according to a new study.

12 Feb 2007

Rate of stem cell transplants among African-Americans lower

Lower transplant rates in ethnic communities may be explained somewhat by a lack of suitable anonymous donors, a problem the medical community has long known and been working to address. Surprisingly, the study found the discrepancy in treatment held true even when the transplant was autologous (e.g. self-donated stem cells were used) or when the cells were donated by a relative, typically a sibling.

11 Feb 2007

What's the best way to treat twin-twin transfusion syndrome?

It's one of the biggest controversies in fetal surgery and the cause of heated debate among surgeons and maternal-fetal medicine physicians around the world: What's the best way to treat twin-twin transfusion syndrome (TTTS), one of the most common conditions requiring fetal surgery and the leading cause of mortality in twins?

11 Feb 2007

Prospective cardiac monitoring in fetuses at risk of congenital heart block

There is an increased risk of fetal heart problems when mothers carry particular antibodies associated with rheumatic diseases, according to an abstract presented by Yale School of Medicine researchers at the Society for Maternal-Fetal Medicine Conference in San Francisco.

11 Feb 2007

South Africa starts major HIV/AIDS vaccine trial

The launch of the first large-scale study to evaluate a candidate HIV vaccine on the African continent was announced today by study collaborators in the United States and South Africa. The trial will involve up to 3,000 participants at five sites throughout South Africa and is expected to continue for four years.

11 Feb 2007